|
|
Memantine - Wikipedia, the free encyclopedia
Memantine is also being tested for opioid dependence, systemic lupus ... 12 (7): 780–4. doi:10.1038/nm0706-780. PMID 16829947. ...
memantine.com - Innovation for Alzheimer Patients
Memantine has been developed by Merz Pharmaceuticals and was recently approved ... Memantine – a new class ... Last change: Feb 11, 2009, 10:13 AM | About Merz ...
Namenda (Memantine), Alzheimer's medication
Namenda (Memantine)is a medication used in the treatment of Alzheimer's. ... shaped, film-coated tablets containing 5 mg and 10 mg of memantine hydrochloride. ...
memantine (Namenda) - drug class, medical uses, medication side effects ...
Specifies the medication memantine (Namenda), a drug used for the treatment of moderate to severe ... PREPARATIONS: Tablets: 5 mg (tan) and 10 mg (gray) ...
memantine.com - Vascular dementia
... randomized double-blind to receive either 10 mg memantine or placebo twice a day. ... Efficacy and Safety of Memantine in Patients With Mild to Moderate ...
Namenda (Memantine HCL) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Namenda (Memantine HCL), drug uses, dosage, side effects, drug ... 5 mg and 10 mg of memantine hydrochloride. ...
Memantine
1% to 10 ... Memantine reduces the decline in function in Alzheimer's disease by ... Memantine hydrochloride 5 mg (28s) and memantine hydrochloride 10 mg (21s) ...
Namenda (memantine)
Namenda (memantine) Generic name: Memantine. Available strengths: 5 mg, 10 mg tablets ... recommended target dosage is 10 mg twice a day (20 mg/day) ...
Memantine - Pubdrug
Memantine exhibits linear pharmacokinetics over the entire the dosage range of 10-40 mg/day. ... 90% of memantine and its metabolites are eliminated via the ...
Buy Memantine (Ebixa) - Optimal Health Products
Buy Memantine (Ebixa) online - 50 x 10 mg tablets Memantine - brand name Ebixa ... Although Memantine has been in use in Germany for nearly 10-years, it is only ...
|
|
|
|
Memantine 10 |
A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-KorsakofWe evaluated the responses of 16 patients to preliminarily explore the spectrum of effectiveness and tolerability of the memantine, and NMDA antagonist, in the treatment of dementia in Wernicke-Korsakoff syndrome. In this study, for the first time in dementia of Wernicke-Korsakoff syndrome, the response to memantine was assessed. 16 patients with median age of 64 years and median body weight of 77 kg were treated with memantine 10 mg twice daily for up to 28 weeks. Clinical global impressions (CGI), and Mini Mental Status Examination (MMSE) were performed during the treatment period (after 2, 4, and 28 weeks). Efficacy measures also included the ADCS-Activities of Daily Living scale (ADCS-ADL). At 28 weeks, the ADCS-ADL showed significantly less deterioration in memantine treated patients compared with placebo (-2.3 compared with -4.3: p = 0.005).
|
Rating: 3.5 èç 5 (ãîëîñîâ: 151) |
|
13 october 2008
Âëàäèìèð Íîâèêîâ
|
|
|
|
|
memantine on
memantine cost
memantine msds
memantine alzheimers
|
|
|
|
|
CATIE-AD: Atypical Antipsychotics Linked to Weight Gain in Older Women
Medscape - Apr 23, 2009
... a cholinesterase inhibitor or memantine, 24% were on cholesterol-lowering medications, and 10% were taking oral blood glucose–lowering medications. ...
Forest Under Fire
Psychiatric Times - Apr 8, 2009
Forest’s 10-Q filed November 10, 2008, noted that the US Attorney’s Office (USAO) had subpoenaed the company and requested documents from 1997 to the ...
FRX
|
|
|
|
|